首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1406806

皮膚科合約研究組織市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按類型、服務類型、地區和競爭細分

Dermatology Contract Research Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Service Type, By Region and Competition

出版日期: 2023年11月07日 | 出版商:

TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2022 年，全球皮膚科合約研究組織 (CRO) 市場價值為 46.5 億美元，預計在預測期內將出現令人印象深刻的成長，到 2028 年複合CAGR為6.11%。近年來，皮膚科領域取得了顯著進步，不斷出現的新療法和療法可解決各種皮膚問題。在這個充滿活力的環境中，合約研究組織 (CRO) 在促進臨床試驗、推動創新以及確保皮膚科產品的安全性和有效性方面發揮關鍵作用。全球皮膚科 CRO 市場已成為該領域的關鍵參與者，具有巨大的成長前景。皮膚科CRO為製藥和生物技術產業提供專業服務，協助開發皮膚科藥物、化妝品和醫療器材。他們的專業知識涵蓋臨床研究的各個方面，包括病患招募、法規遵循、資料管理和品質保證。由於幾個關鍵因素，全球皮膚科 CRO 市場一直在快速擴張。

在全球範圍內，痤瘡、牛皮癬、濕疹和皮膚癌等皮膚相關疾病的盛行率正在上升。皮膚病的激增導致對創新療法和療法的需求增加，從而推動了 CRO 進行臨床試驗的需求。皮膚病學研究的突破促進了生物製劑、基因療法和個人化醫療等先進療法的發展。皮膚科 CRO 處於對這些尖端治療進行臨床試驗的最前沿。皮膚科產品的嚴格監管要求需要專門的知識和專業知識。專門從事皮膚病學的 CRO 可以幫助應對複雜的監管環境，確保產品安全和合規性。製藥公司擴大將臨床試驗外包給 CRO，以簡化營運並降低成本。皮膚科 CRO 專注於利基市場，使製藥公司能夠利用其專業技能。以患者為中心已成為臨床試驗的一個重要焦點，皮膚科 CRO 正在採用創新策略來加強患者招募和參與，最終改善試驗結果。

主要市場促進因素

市場概況
預測期	2024-2028
2022 年市場規模	46.5億美元
2028 年市場規模	65.8億美元
2023-2028 年CAGR	6.11%
成長最快的細分市場	藥物發現
最大的市場	北美洲

皮膚病患病率的增加正在推動全球皮膚病學合約研究組織 (CRO) 市場的發展

IQVIA 公司
- Business Overview
- Service Type Offerings
- Recent Developments
- Key Personnel
- SWOT Analysis
阿拉根生命科學有限公司
醫藥產品開發公司（Thermo Fisher Scientific Inc.）
精銳國際公司
查爾斯河實驗室
圖標，PLC
醫療數據解決方案
Syneos 健康私人有限公司
康龍化成有限公司
無錫藥明康德

第 14 章：策略建議

關於我們及免責聲明

簡介目錄

Product Code: 19782

Global Dermatology Contract Research Organization (CRO) Market has valued at USD 4.65 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.11% through 2028. The field of dermatology has witnessed remarkable advancements in recent years, with new treatments and therapies emerging to address a wide range of skin conditions. In this dynamic landscape, contract research organizations (CROs) have played a pivotal role in facilitating clinical trials, driving innovation, and ensuring the safety and efficacy of dermatological products. The Global Dermatology CRO Market has emerged as a key player in this domain, with significant growth prospects. Dermatology CROs provide specialized services for the pharmaceutical and biotechnology industries, assisting in the development of dermatological drugs, cosmetics, and medical devices. Their expertise encompasses various aspects of clinical research, including patient recruitment, regulatory compliance, data management, and quality assurance. The global dermatology CRO market has been expanding rapidly due to several key factors.

The prevalence of skin-related conditions, such as acne, psoriasis, eczema, and skin cancer, is on the rise globally. This surge in dermatological disorders has led to increased demand for innovative treatments and therapies, driving the need for clinical trials conducted by CROs. Breakthroughs in dermatological research have resulted in the development of advanced therapies like biologics, gene therapy, and personalized medicine. Dermatology CROs are at the forefront of conducting clinical trials for these cutting-edge treatments. Stringent regulatory requirements for dermatological products necessitate specialized knowledge and expertise. CROs specializing in dermatology can help navigate the complex regulatory landscape, ensuring product safety and compliance. Pharmaceutical companies are increasingly outsourcing their clinical trials to CROs to streamline operations and reduce costs. Dermatology CROs offer a niche focus, allowing pharmaceutical companies to leverage their specialized skills. Patient-centricity has become a significant focus in clinical trials, and dermatology CROs are adopting innovative strategies to enhance patient recruitment and engagement, ultimately improving trial outcomes.

Key Market Drivers

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 4.65 Billion
Market Size 2028	USD 6.58 Billion
CAGR 2023-2028	6.11%
Fastest Growing Segment	Drug Discovery
Largest Market	North America

Increasing Prevalence of Skin Disorders is Driving the Global Dermatology Contract Research Organization (CRO) Market

The global dermatology contract research organization (CRO) market is witnessing significant growth, primarily driven by the increasing prevalence of skin disorders worldwide. Dermatological conditions affect millions of people globally, leading to a growing demand for research and development activities to discover effective treatments and therapies. Dermatology CROs play a pivotal role in advancing the field by conducting clinical trials, ensuring the safety and efficacy of new products, and accelerating the development of innovative dermatological solutions. Skin disorders encompass a wide range of conditions, from common ones like acne, eczema, and psoriasis to more severe ailments like melanoma and other forms of skin cancer. The prevalence of these conditions has been on the rise in recent years, driven by various factors such as lifestyle changes, environmental factors, and genetics.

Modern lifestyles often involve increased exposure to pollution, harmful UV rays, and stress, all of which can contribute to the development of skin disorders. Climate change and environmental pollution have led to an increase in skin-related issues, including allergic reactions and skin sensitivities. Genetic predisposition to certain skin disorders is a reality for many individuals, making them more susceptible to conditions such as psoriasis or eczema. As the global population continues to age, the prevalence of age-related skin conditions like wrinkles, age spots, and skin sagging is also increasing.

The global dermatology CRO market is experiencing robust growth due to the increasing demand for dermatological research services. Pharmaceutical companies are actively investing in dermatological R&D to address the rising prevalence of skin disorders and tap into this lucrative market. Moreover, the development of innovative therapies, such as biologics and targeted treatments, is driving the need for specialized CRO expertise. Additionally, the COVID-19 pandemic has underscored the importance of clinical research and the role of CROs in expediting the development of vaccines and treatments. This increased recognition has also spilled over into the dermatology CRO sector, further fueling its growth.

Increasing Regulatory Compliance and Quality Assurance is Driving the Global Dermatology Contract Research Organization (CRO) Market

Dermatology research often involves the development of pharmaceuticals, medical devices, and cosmetic products, all of which are subject to rigorous regulatory oversight. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have stringent requirements for safety, efficacy, and quality for products intended for dermatological use. Achieving and maintaining compliance with these regulations is a complex and resource-intensive process. Dermatology CROs specialize in navigating the complex landscape of regulatory requirements. They have expertise in designing and conducting clinical trials, ensuring that studies are conducted in accordance with Good Clinical Practice (GCP) guidelines. This expertise is invaluable to pharmaceutical and biotechnology companies seeking to bring dermatological products to market, as it reduces the risk of regulatory setbacks and delays.

Quality assurance is paramount in dermatology research, where even small variations in product formulation or manufacturing processes can have significant implications for patient safety and product effectiveness. Dermatology CROs play a crucial role in maintaining the highest standards of quality throughout the research and development process. These organizations employ comprehensive quality management systems to ensure that every aspect of a study, from data collection to analysis and reporting, adheres to established protocols and guidelines. This rigorous approach not only ensures regulatory compliance but also helps mitigate risks and enhances the credibility of research findings.

Key Market Challenges

Diverse Range of Dermatological Conditions

One of the primary challenges faced by CROs in the dermatology sector is the wide variety of dermatological conditions that require clinical trials and research. Dermatology encompasses a vast array of diseases, from common conditions like acne and psoriasis to rare disorders like epidermolysis bullosa. Conducting trials for such a diverse range of conditions requires specialized expertise, resources, and patient populations.

Solution: Dermatology CROs can address this challenge by building specialized teams with expertise in different dermatological conditions. Collaboration with academic institutions and patient advocacy groups can help in accessing the right patient populations for clinical trials.

Evolving Regulatory Environment

The regulatory landscape in the pharmaceutical and dermatology sectors is constantly evolving. New guidelines and regulations can significantly impact the design and execution of clinical trials. Staying up-to-date with regulatory changes and ensuring compliance is a continuous challenge for CROs.

Solution: Establishing strong relationships with regulatory agencies and maintaining a proactive approach to compliance is essential. CROs should also invest in ongoing training and education for their staff to stay informed about regulatory updates.

Recruitment and Retention of Patients

Recruiting and retaining patients for dermatology clinical trials can be challenging. Patients often have concerns about the safety and efficacy of experimental treatments, and they may be hesitant to participate. Additionally, finding suitable patient populations for rare dermatological conditions can be a time-consuming process.

Solution: Effective patient engagement strategies, such as clear communication, informed consent processes, and patient-centric trial designs, can help build trust and encourage participation. Collaboration with patient advocacy groups can also assist in identifying and recruiting eligible patients.

Data Quality and Endpoint Assessment

Accurate data collection and robust endpoint assessment are crucial in dermatology trials. Assessing endpoints like disease severity and treatment efficacy can be subjective, leading to potential biases and variability in data.

Solution: Implementing standardized assessment tools and training investigators to ensure consistent data collection can help mitigate variability. Independent endpoint adjudication committees can also provide unbiased assessments of treatment efficacy.

Competition and Pricing Pressure

The global CRO market is highly competitive, and pricing pressures can be intense. Clients often demand cost-effective solutions while expecting high-quality research services.

Solution: CROs should focus on delivering value through efficient trial management, data quality, and innovative approaches. Building strong relationships with clients and demonstrating a track record of success can help justify pricing.

Access to Dermatology Experts

Finding and retaining skilled dermatologists and clinical research professionals can be challenging, especially in regions with limited access to specialized expertise.

Solution: Collaboration with academic institutions and professional networks can help CROs tap into a pool of experienced dermatology experts. Offering attractive career opportunities and professional development can also aid in talent retention.

Key Market Trends

Technological Advancements

The field of dermatology has seen remarkable technological advancements in recent years, and these innovations are not only transforming patient care but also driving growth in the Global Dermatology Contract Research Organization (CRO) Market. Dermatology CROs play a pivotal role in the development and testing of new pharmaceuticals, therapies, and medical devices for skin-related conditions. The integration of cutting-edge technologies in dermatological research has created fertile ground for collaboration between pharmaceutical companies, research institutions, and CROs.

Advances in genomics and molecular biology have opened doors to precision medicine in dermatology. The ability to analyze an individual's genetic makeup and identify specific markers related to skin conditions has led to the development of personalized treatments. Dermatology CROs are increasingly using genetic testing and molecular profiling to tailor therapies to individual patients, thus enhancing treatment efficacy and minimizing adverse effects. This precision approach not only benefits patients but also attracts pharmaceutical companies seeking CROs with expertise in this field.

AI and machine learning have found significant applications in dermatology, particularly in the field of dermatopathology and image analysis. Dermatology CROs are utilizing AI algorithms to aid in the early detection of skin cancers, analyze skin lesions, and evaluate the efficacy of treatments. These technologies can process vast amounts of data quickly and accurately, allowing for more efficient and reliable clinical trials. Pharmaceutical companies are increasingly partnering with CROs that have integrated AI capabilities into their research protocols, enabling faster and more cost-effective drug development. The rise of telemedicine and remote monitoring technologies has transformed how dermatology clinical trials are conducted. Patients can now participate in studies from the comfort of their homes, reducing the need for in-person visits and the associated costs. Dermatology CROs are leveraging telemedicine platforms to facilitate remote patient monitoring, data collection, and even virtual consultations with dermatologists. This not only enhances patient recruitment and retention but also accelerates the pace of clinical trials.

Innovations in 3D printing and bioengineering have introduced new possibilities in the development of dermatological products. Dermatology CROs are using 3D printing to create custom implants, wound dressings, and drug delivery systems tailored to individual patients. Bioengineered skin substitutes are being explored as potential solutions for burn victims and patients with chronic skin conditions. These advancements are attracting pharmaceutical companies looking to collaborate with CROs capable of pioneering novel solutions. The ability to harness real-world data is a game-changer for dermatology research. Dermatology CROs are increasingly relying on data analytics to extract insights from electronic health records, patient registries, and wearable devices. This real-world evidence allows for a more comprehensive understanding of treatment outcomes, safety profiles, and patient preferences. Pharmaceutical companies value CROs that can incorporate real-world data into their clinical trial designs, facilitating faster drug approvals and market access.

Segmental Insights

Type Insights

Based on the category of Type, Clinical emerged as the dominant player in the global market for Dermatology Contract Research Organization (CRO) in 2022. Clinical CROs offer a wide range of services, including Phase I to Phase IV trials, patient recruitment and retention strategies, data management, and regulatory support. This diversity makes them attractive partners for sponsors seeking comprehensive solutions. Clinical CROs have expanded their operations globally, establishing a strong presence in emerging markets. This allows them to tap into diverse patient populations and leverage cost-effective resources, further bolstering their dominance. The pharmaceutical and biotechnology industries are continually investing in research and development efforts to bring innovative dermatological treatments to market. Clinical CROs provide the expertise and infrastructure needed to conduct comprehensive clinical trials.

Service Type Insights

The Regulatory/Medical Affairs segment is projected to experience rapid growth during the forecast period. Regulatory/Medical Affairs experts work closely with dermatology CROs and pharmaceutical companies to develop comprehensive regulatory strategies. These strategies are essential for the successful approval and market entry of dermatological products. They involve assessing the regulatory requirements of different regions, planning submission timelines, and anticipating potential challenges. Regulatory/Medical Affairs professionals play a pivotal role in designing and managing clinical trials for dermatological products. They ensure that trials are conducted ethically, in compliance with regulatory guidelines, and produce robust data. Properly designed trials are crucial for obtaining regulatory approvals. Ensuring the safety of dermatological products is paramount. Regulatory/Medical Affairs experts work tirelessly to monitor safety data throughout a product's lifecycle, promptly report adverse events, and comply with post-market surveillance requirements. The submission of regulatory documents is a critical phase in gaining approval for dermatological products. Regulatory/Medical Affairs specialists are responsible for compiling and submitting applications to regulatory authorities, such as the FDA in the United States or the European Medicines Agency (EMA) in Europe. They navigate the intricacies of different regulatory pathways and communicate with regulatory agencies on behalf of their clients.

Regional Insights

North America emerged as the dominant player in the global Dermatology Contract Research Organization (CRO) market in 2022, holding the largest market share in terms of value. North America boasts a robust research infrastructure, including world-renowned universities, medical centers, and pharmaceutical hubs. These institutions foster collaboration and innovation in dermatological research, making the region an ideal location for CROs. North American CROs have access to cutting-edge technologies and state-of-the-art facilities. This technological advantage allows them to conduct advanced clinical trials, collect high-quality data, and expedite the development of novel dermatological products. The North American regulatory environment is well-established, and CROs in the region have extensive experience in navigating regulatory processes. This expertise ensures that clinical trials meet all compliance requirements, facilitating faster approvals.

Key Market Players

IQVIA, Inc

Aragen Life Sciences Ltd

Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)

Parexel International Corporation

Charles River Laboratories

Icon, Plc

Medidata Solutions

Syneos Health pvt ltd.

S Pharmaron inc.

Wuxi Apptec

Report Scope:

In this report, the Global Dermatology Contract Research Organization (CRO) Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermatology Contract Research Organization (CRO) Market, By Type:

Drug Discovery
Preclinical
Clinical

Dermatology Contract Research Organization (CRO) Market, By Service Type:

Laboratory
Technology
Medical Writing
Regulatory/Medical Affairs Others

Dermatology Contract Research Organization (CRO) Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Dermatology Contract Research Organization (CRO) Market.

Available Customizations:

Global Dermatology Contract Research Organization (CRO) market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermatology Contract Research Organization (CRO) Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type ( Drug Discovery, Preclinical, Clinical)
- 5.2.2. By Service Type (Laboratory, Technology, Medical Writing, Regulatory/Medical Affairs, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2022)
5.3. Market Map
- 5.3.1. By Type
- 5.3.2. By Service Type
- 5.3.3. By Region

6. North America Dermatology Contract Research Organization (CRO) Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Service Type
- 6.2.3. By Country
  - 6.2.3.1. United States Dermatology Contract Research Organization (CRO) Market Outlook
    - 6.2.3.1.1. Market Size & Forecast
    - 6.2.3.1.1.1. By Value
    - 6.2.3.1.2. Market Share & Forecast
    - 6.2.3.1.2.1. By Type
    - 6.2.3.1.2.2. By Service Type
  - 6.2.3.2. Canada Dermatology Contract Research Organization (CRO) Market Outlook
    - 6.2.3.2.1. Market Size & Forecast
    - 6.2.3.2.1.1. By Value
    - 6.2.3.2.2. Market Share & Forecast
    - 6.2.3.2.2.1. By Type
    - 6.2.3.2.2.2. By Service Type
  - 6.2.3.3. Mexico Dermatology Contract Research Organization (CRO) Market Outlook
    - 6.2.3.3.1. Market Size & Forecast
    - 6.2.3.3.1.1. By Value
    - 6.2.3.3.2. Market Share & Forecast
    - 6.2.3.3.2.1. By Type
    - 6.2.3.3.2.2. By Service Type

7. Europe Dermatology Contract Research Organization (CRO) Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Service Type
- 7.2.3. By Country
  - 7.2.3.1. France Dermatology Contract Research Organization (CRO) Market Outlook
    - 7.2.3.1.1. Market Size & Forecast
    - 7.2.3.1.1.1. By Value
    - 7.2.3.1.2. Market Share & Forecast
    - 7.2.3.1.2.1. By Type
    - 7.2.3.1.2.2. By Service Type
  - 7.2.3.2. Germany Dermatology Contract Research Organization (CRO) Market Outlook
    - 7.2.3.2.1. Market Size & Forecast
    - 7.2.3.2.1.1. By Value
    - 7.2.3.2.2. Market Share & Forecast
    - 7.2.3.2.2.1. By Type
    - 7.2.3.2.2.2. By Service Type
  - 7.2.3.3. United Kingdom Dermatology Contract Research Organization (CRO) Market Outlook
    - 7.2.3.3.1. Market Size & Forecast
    - 7.2.3.3.1.1. By Value
    - 7.2.3.3.2. Market Share & Forecast
    - 7.2.3.3.2.1. By Type
    - 7.2.3.3.2.2. By Service Type
  - 7.2.3.4. Italy Dermatology Contract Research Organization (CRO) Market Outlook
    - 7.2.3.4.1. Market Size & Forecast
    - 7.2.3.4.1.1. By Value
    - 7.2.3.4.2. Market Share & Forecast
    - 7.2.3.4.2.1. By Type
    - 7.2.3.4.2.2. By Service Type
  - 7.2.3.5. Spain Dermatology Contract Research Organization (CRO) Market Outlook
    - 7.2.3.5.1. Market Size & Forecast
    - 7.2.3.5.1.1. By Value
    - 7.2.3.5.2. Market Share & Forecast
    - 7.2.3.5.2.1. By Type
    - 7.2.3.5.2.2. By Service Type

8. Asia Pacific Dermatology Contract Research Organization (CRO) Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Service Type
- 8.2.3. By Country
  - 8.2.3.1. China Dermatology Contract Research Organization (CRO) Market Outlook
    - 8.2.3.1.1. Market Size & Forecast
    - 8.2.3.1.1.1. By Value
    - 8.2.3.1.2. Market Share & Forecast
    - 8.2.3.1.2.1. By Type
    - 8.2.3.1.2.2. By Service Type
  - 8.2.3.2. India Dermatology Contract Research Organization (CRO) Market Outlook
    - 8.2.3.2.1. Market Size & Forecast
    - 8.2.3.2.1.1. By Value
    - 8.2.3.2.2. Market Share & Forecast
    - 8.2.3.2.2.1. By Type
    - 8.2.3.2.2.2. By Service Type
  - 8.2.3.3. South Korea Dermatology Contract Research Organization (CRO) Market Outlook
    - 8.2.3.3.1. Market Size & Forecast
    - 8.2.3.3.1.1. By Value
    - 8.2.3.3.2. Market Share & Forecast
    - 8.2.3.3.2.1. By Type
    - 8.2.3.3.2.2. By Service Type
  - 8.2.3.4. Japan Dermatology Contract Research Organization (CRO) Market Outlook
    - 8.2.3.4.1. Market Size & Forecast
    - 8.2.3.4.1.1. By Value
    - 8.2.3.4.2. Market Share & Forecast
    - 8.2.3.4.2.1. By Type
    - 8.2.3.4.2.2. By Service Type
  - 8.2.3.5. Australia Dermatology Contract Research Organization (CRO) Market Outlook
    - 8.2.3.5.1. Market Size & Forecast
    - 8.2.3.5.1.1. By Value
    - 8.2.3.5.2. Market Share & Forecast
    - 8.2.3.5.2.1. By Type
    - 8.2.3.5.2.2. By Service Type

9. South America Dermatology Contract Research Organization (CRO) Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Service Type
- 9.2.3. By Country
  - 9.2.3.1. Brazil Dermatology Contract Research Organization (CRO) Market Outlook
    - 9.2.3.1.1. Market Size & Forecast
    - 9.2.3.1.1.1. By Value
    - 9.2.3.1.2. Market Share & Forecast
    - 9.2.3.1.2.1. By Type
    - 9.2.3.1.2.2. By Service Type
  - 9.2.3.2. Argentina Dermatology Contract Research Organization (CRO) Market Outlook
    - 9.2.3.2.1. Market Size & Forecast
    - 9.2.3.2.1.1. By Value
    - 9.2.3.2.2. Market Share & Forecast
    - 9.2.3.2.2.1. By Type
    - 9.2.3.2.2.2. By Service Type
  - 9.2.3.3. Colombia Dermatology Contract Research Organization (CRO) Market Outlook
    - 9.2.3.3.1. Market Size & Forecast
    - 9.2.3.3.1.1. By Value
    - 9.2.3.3.2. Market Share & Forecast
    - 9.2.3.3.2.1. By Type
    - 9.2.3.3.2.2. By Service Type

10. Middle East & Africa Dermatology Contract Research Organization (CRO) Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Service Type
- 10.2.3. By Country
  - 10.2.3.1. South Africa Dermatology Contract Research Organization (CRO) Market Outlook
    - 10.2.3.1.1. Market Size & Forecast
    - 10.2.3.1.1.1. By Value
    - 10.2.3.1.2. Market Share & Forecast
    - 10.2.3.1.2.1. By Type
    - 10.2.3.1.2.2. By Service Type
  - 10.2.3.2. Saudi Arabia Dermatology Contract Research Organization (CRO) Market Outlook
    - 10.2.3.2.1. Market Size & Forecast
    - 10.2.3.2.1.1. By Value
    - 10.2.3.2.2. Market Share & Forecast
    - 10.2.3.2.2.1. By Type
    - 10.2.3.2.2.2. By Service Type
  - 10.2.3.3. UAE Dermatology Contract Research Organization (CRO) Market Outlook
    - 10.2.3.3.1. Market Size & Forecast
    - 10.2.3.3.1.1. By Value
    - 10.2.3.3.2. Market Share & Forecast
    - 10.2.3.3.2.1. By Type
    - 10.2.3.3.2.2. By Service Type

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Service Type Launches

13. Competitive Landscape

13.1. IQVIA, Inc
- 13.1.1. Business Overview
- 13.1.2. Service Type Offerings
- 13.1.3. Recent Developments
- 13.1.4. Key Personnel
- 13.1.5. SWOT Analysis
13.2. Aragen Life Sciences Ltd
13.3. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
13.4. Parexel International Corporation
13.5. Charles River Laboratories
13.6. Icon, Plc
13.7. Medidata Solutions
13.8. Syneos Health pvt ltd.
13.9. S Pharmaron inc.
13.10. Wuxi Apptec